Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts on ‘September 30th, 2009’

KCI Highlights ABThera Open Abdomen Negative Pressure Therapy System at American Association for the Surgery of Trauma Conference Symposium

Company Also Introduces New U.S. Open Abdomen Management System Medical Guidelines SAN ANTONIO–(HSMN NewsFeed)–Kinetic Concepts, Inc. (NYSE: KCI ) will highlight the latest addition to the KCI Negative Pressure Technology Platform (NPTP), the ABThera…
Devices, Wound Care
Kinetic Concepts, Negative Pressure Wound Therapy, ABThera

Cardo Lab Announces the Introduction and First Successful Implantation of the Align 360(TM) Total Knee System

LOS ANGELES, Sept. 30, 2009 –(HSMN NewsFeed) — Cardo Pharmaceutical (OTCBB:CDOM ), a company engaged in the development of orthopedic clinical devices, announces the introduction and first successful implantation of the Align 360(TM) Total Knee system. The initi…
Devices, Orthopaedic
Cardo Medical, Align 360, Total Knee, Uni-Compartmental

Aileron Appoints Industry Veteran Diane Jorkasky, M.D., as Company’s Head of Development and Chief Clinical Officer

R&D Leader Joins Aileron from Pfizer to Build Pipeline of Novel Stapled Peptide Drugs CAMBRIDGE, Mass., Sept., 30–(HSMN NewsFeed)–Aileron Therapeutics, a biotechnology company discovering and developing a novel class of therapeutics called Stapled Pep…
Biopharmaceuticals, Personnel
Aileron Therapeutics

Mylan Receives FDA Approval for Generic Version of Parkinson’s Treatment Sinemet(R)

PITTSBURGH, Sept. 30 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ca…
Biopharmaceuticals, Generics, Neurology, FDA
Mylan, Mylan Pharmaceuticals, Carbidopa, Levodopa, Sinemet